Login to Your Account

Financings Roundup

Friday, February 18, 2011
Rosetta Genomics Ltd., of Rehovot, Israel, entered agreements with investors to purchase $6 million in securities in concurrent private placement and registered direct offerings.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription